Changes in glycemic and weight-related outcomes
Participants in the intervention group experienced a significant decline of 0.37 mmol/L in FBG compared with 0.09 mmol/L in the control group from baseline to 18-month follow-up (β = −.169 [95%CI −.252, −.087]; There was a significant decrease of 1.07 kg/m